Hos patienter med YMDD- variant HBV udviste 41/ 82 (50%) patienter forbedring af leverinflammation og 40/ 56 (71%) patienter uden YMDD- variant HBV udviste forbedring.
In patients with YMDD variant HBV, 41/ 82 (50%) patients had improvement in liver inflammation and 40/ 56 (71%) patients without YMDD variant HBV had improvement.